These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 18650266)
1. Chemotoxicity of doxorubicin and surface expression of P-glycoprotein (MDR1) is regulated by the Pseudomonas aeruginosa toxin Cif. Ye S; MacEachran DP; Hamilton JW; O'Toole GA; Stanton BA Am J Physiol Cell Physiol; 2008 Sep; 295(3):C807-18. PubMed ID: 18650266 [TBL] [Abstract][Full Text] [Related]
2. Drug concentration-dependent expression of multidrug resistance-associated protein and P-glycoprotein in the doxorubicin-resistant acute myelogenous leukemia sublines. Choi CH; Kim HS; Rha HS; Jeong JH; Park YH; Min YD; Kee KH; Lim DY Mol Cells; 1999 Jun; 9(3):314-9. PubMed ID: 10420992 [TBL] [Abstract][Full Text] [Related]
3. Protein kinase Cα protects against multidrug resistance in human colon cancer cells. Lee SK; Shehzad A; Jung JC; Sonn JK; Lee JT; Park JW; Lee YS Mol Cells; 2012 Jul; 34(1):61-9. PubMed ID: 22639047 [TBL] [Abstract][Full Text] [Related]
4. Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil. Kakumoto M; Sakaeda T; Takara K; Nakamura T; Kita T; Yagami T; Kobayashi H; Okamura N; Okumura K Cancer Sci; 2003 Jan; 94(1):81-6. PubMed ID: 12708479 [TBL] [Abstract][Full Text] [Related]
5. Anthracyclines, proteasome activity and multi-drug-resistance. Fekete MR; McBride WH; Pajonk F BMC Cancer; 2005 Sep; 5():114. PubMed ID: 16159384 [TBL] [Abstract][Full Text] [Related]
6. Novel pyxinol amide derivatives bearing an aliphatic heterocycle as P-glycoprotein modulators for overcoming multidrug resistance. Yu L; Ren R; Li S; Zhang C; Chen C; Lv H; Zou Z; Pei X; Song Z; Zhang P; Wang H; Yang G Eur J Med Chem; 2024 Jun; 272():116466. PubMed ID: 38704938 [TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the cystic fibrosis transmembrane conductance regulator inhibitory factor Cif reveals novel active-site features of an epoxide hydrolase virulence factor. Bahl CD; Morisseau C; Bomberger JM; Stanton BA; Hammock BD; O'Toole GA; Madden DR J Bacteriol; 2010 Apr; 192(7):1785-95. PubMed ID: 20118260 [TBL] [Abstract][Full Text] [Related]
8. Small molecules that dramatically alter multidrug resistance phenotype by modulating the substrate specificity of P-glycoprotein. Kondratov RV; Komarov PG; Becker Y; Ewenson A; Gudkov AV Proc Natl Acad Sci U S A; 2001 Nov; 98(24):14078-83. PubMed ID: 11707575 [TBL] [Abstract][Full Text] [Related]
9. Potentiation of Low-Dose Doxorubicin Cytotoxicity by Affecting P-Glycoprotein through Caryophyllane Sesquiterpenes in HepG2 Cells: an in Vitro and in Silico Study. Di Sotto A; Irannejad H; Eufemi M; Mancinelli R; Abete L; Mammola CL; Altieri F; Mazzanti G; Di Giacomo S Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963614 [TBL] [Abstract][Full Text] [Related]
10. Pim-1 kinase protects P-glycoprotein from degradation and enables its glycosylation and cell surface expression. Xie Y; Burcu M; Linn DE; Qiu Y; Baer MR Mol Pharmacol; 2010 Aug; 78(2):310-8. PubMed ID: 20460432 [TBL] [Abstract][Full Text] [Related]
11. Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma. Buondonno I; Gazzano E; Tavanti E; Chegaev K; Kopecka J; Fanelli M; Rolando B; Fruttero R; Gasco A; Hattinger C; Serra M; Riganti C Cell Mol Life Sci; 2019 Feb; 76(3):609-625. PubMed ID: 30430199 [TBL] [Abstract][Full Text] [Related]
13. Cytoprotective effects of acidosis via heat shock protein HSP27 against the anticancer drug doxorubicin. Singh AK; Manns MP; Seidler U Cell Mol Life Sci; 2011 Mar; 68(6):1041-51. PubMed ID: 20730553 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of multidrug recognition by MDR1/ABCB1. Kimura Y; Morita SY; Matsuo M; Ueda K Cancer Sci; 2007 Sep; 98(9):1303-10. PubMed ID: 17608770 [TBL] [Abstract][Full Text] [Related]
15. Significance of MDR1 and multiple drug resistance in refractory human epileptic brain. Marchi N; Hallene KL; Kight KM; Cucullo L; Moddel G; Bingaman W; Dini G; Vezzani A; Janigro D BMC Med; 2004 Oct; 2():37. PubMed ID: 15473912 [TBL] [Abstract][Full Text] [Related]
16. P-Glycoprotein/MDR1 regulates pokemon gene transcription through p53 expression in human breast cancer cells. He S; Liu F; Xie Z; Zu X; Xu W; Jiang Y Int J Mol Sci; 2010 Aug; 11(9):3309-051. PubMed ID: 20957096 [TBL] [Abstract][Full Text] [Related]
17. Drug-Induced Conformational Dynamics of P-Glycoprotein Underlies the Transport of Camptothecin Analogs. Mensah GAK; Schaefer KG; Bartlett MG; Roberts AG; King GM Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003248 [TBL] [Abstract][Full Text] [Related]
18. Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3 signaling. Riganti C; Salaroglio IC; Pinzòn-Daza ML; Caldera V; Campia I; Kopecka J; Mellai M; Annovazzi L; Couraud PO; Bosia A; Ghigo D; Schiffer D Cell Mol Life Sci; 2014 Feb; 71(3):499-516. PubMed ID: 23771630 [TBL] [Abstract][Full Text] [Related]
19. Nanocarriers enhance Doxorubicin uptake in drug-resistant ovarian cancer cells. Arora HC; Jensen MP; Yuan Y; Wu A; Vogt S; Paunesku T; Woloschak GE Cancer Res; 2012 Feb; 72(3):769-78. PubMed ID: 22158944 [TBL] [Abstract][Full Text] [Related]